Both olanzapine and clozapine produced significant dose and time dependent effects on fasting plasma glucose and insulin concentrations, HOMA-IR values, insulin resistance and glucose intolerance (Boyda et al., 2010b; Liu et al., 2017). The gene discussed is INS; the disease is Insulin resistance.